Q3 Top Pharma Company Earnings Reports

The summer is fading fast, the leaves are changing from green to gold and red, and days have gotten shorter as we turn our clocks back from daylight savings time. So what season is upon us? Earnings season of course!

We've compiled the earnings reports from some of the top companies in Pharma with brief summaries, links to some of our articles and some quick highlights of some of the more important facts. Check out the list below or just click through all of our reports on these companies:

Read more on

Suggested Articles

In previously untreated nonsquamous NSCLC, a Tyvyt-chemo combo beat chemo alone at stalling the time to tumor progression or death.

It’s been a big year for Bristol's Opdivo-Yervoy combo in lung cancer, but with new mesothelioma data in hand, the duo isn’t done making headlines.

A third spinal muscular atrophy treatment option is set to debut with the FDA’s approval for Roche’s Evrysdi, formerly known as risdiplam.